Brazil Says Chinese Vaccine Trial Can Resume After Suspension

Brazil health regulator Anvisa on Wednesday allowed resumption of latestage Brazilian clinical trials for China's Sinovac COVID19 vaccine, which had been suspended due to a study subject's death that was registered in Sao Paulo as a suicide.

from Top Business News- News18.com https://ift.tt/3ng2byp